Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Bone, Angie ^a,b   Guthmann, Jean Paul ^a   Assal, Azzedine ^c   Rousset, Dominique ^d   Degeorges, Armelle ^c   Morel, Pascal ^c   Valette, Martine ^e   Enouf, Vincent ^d   Jacquot, Eric ^c   Pelletier, Bertrand ^c   Le Strat, Yann ^a   Pillonel, Josiane ^a   Fonteneau, Laure ^a   van der Werf, Sylvie ^d,f,g   Lina, Bruno ^e   Tiberghien, Pierre ^c   Lévy Bruhl, Daniel ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d INSTITUT PASTEUR   (France)

^e UNIVERSITÉ LYON 1   (France)

^f CNRS   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2009 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SURVEILLANCE; ETHNIC GROUP; FEMALE; FRANCE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; RISK ASSESSMENT; SEASONAL INFLUENZA; SEROCONVERSION; SEROPREVALENCE; SEX DIFFERENCE; WINTER; BLOOD; EPIDEMIOLOGY; INCIDENCE; INFLUENZA; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; MIDDLE AGED; VIROLOGY;

ADULT; AGED; BLOOD DONORS; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HUMANS; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES;

EID: 84858737136     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033056     Document Type: Article

References (43)

1. Institut de Veille Sanitaire (2010) [Weekly Epidemiological Bulletin influenza A (H1N1) 2009. Situation Update 20 April 2010.]Bulletin hebdomadaire grippe. Point de situation au 20 avril 2010. Available at:http://www.invs.sante.fr/surveillance/grippe_dossier/points_grippe/grippe_200410/Bulletin_grippe_200410.pdf. Accessed 2011 June 08.
2. Institut de Veille Sanitaire (2009) [Estimations of the number of infections of influenza A (H1N1) 2009 in mainland France 17 December 2010.] Estimations du nombre d'infections de grippe A(H1N1)2009 en France métropolitaine au 17 décembre 2009. Available at:http://www.invs.sante.fr/surveillance/grippe_dossier/docs_professionnels/estimation_cas_graves_grippe_a_h1n1_171209.pdf Accessed 2011 June 08.
3. Bone A, Guthmann JP, Nicolau J, Levy-Bruhl D, (2010) Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign. Vaccine 28: 8157-8161.
4. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, et al. (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375: 1100-1108.
5. Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec 85: 229-235.
6. Chen MI, Lee VJ, Lim WY, Barr IG, Lin RT, et al. (2010) 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 303: 1383-1391.
7. Riley S, Kwok KO, Wu KM, Ning DY, Cowling BJ, et al. (2011) Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med 8: e1000442.
8. Wu JT, Ma ES, Lee CK, Chu DK, Ho PL, et al. (2010) The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 51: 1184-1191.
9. Institut nationale de la statistique et des etudes economiques (2011) Table d'appartenance géographique des communes. Available at: http://www.insee.fr/fr/themes/detail.asp?reg_id=99&ref_id=base-cc-table-appartenance-geo-communes. Accessed 2011 June 08.
10. Zambon MC, (1998) Laboratory Diagnosis of Influenza. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of Influenza Oxford, United Kingdom Blackwell pp. 291-313.
11. Palmer DF, Dowdle WR, Coleman MT, Schild GC, (1975) Procedural guide, Part 2: Haemmagglutination-inhibition test, 1975, 25-62. Advanced laboratory technicals for immunological diagnostic U.S. Dept. Hlth., Ed. Welfare, P.H.S. Atlanta Immunology Ser. nR6.
12. de Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, (2003) Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 115: 63-73.
13. Barros AJ, Hirakata VN, (2003) Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 3: 21.
14. Perruccio AV, Power JD, Badley EM, (2007) The relative impact of 13 chronic conditions across three different outcomes. J Epidemiol Community Health 61: 1056-1061.
15. Stata Statistical Software: Release 11 (2011) StataCorp. 2009. College Station, TX: StataCorp LP., version.
16. Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, et al. (2010) Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One 5: e13211.
17. Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, (2010) Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS One 5: e12562.
18. McLeish NJ, Simmonds P, Robertson C, Handel I, McGilchrist M, et al. (2011) Sero-Prevalence and Incidence of A/H1N1 2009 Influenza Infection in Scotland in Winter 2009-2010. PLoS One 6 (6): e20358 doi:10.1371/journal.pone.0020358.
19. Delangue J, Salez N, Ninove L, Kieffer A, Zandotti C, et al. (2011) Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population. Clin Microbiol Infect.
20. Dudareva S, Schweiger B, Thamm M, Hohle M, Stark K, et al. (2011) Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period. PLoS One 6: e21340.
21. Baguelin M, Hoschler K, Stanford E, Waight P, Hardelid P, et al. (2011) Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation. PLoS One 6: e17074.
22. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, et al. (2008) Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 167: 775-785.
23. Tandale BV, Pawar SD, Gurav YK, Chadha MS, Koratkar SS, et al. (2010) Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. BMC Infect Dis 10: 255.
24. Flahault A, de Lamballerie X, Pellat C, Salez N, Hanslik T, (2009) Symptomatic infections less frequent with H1N1pdm than with seasonal strains: PLoS Curr Influenza RRN1140.
25. Chan YJ, Lee CL, Hwang SJ, Fung CP, Wang FD, (2010) Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan. J Chin Med Assoc 73: 62-66.
26. Rizzo C, Rota MC, Bella A, Alfonsi V, Declich S, et al. (2010) Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine 28: 3558-3562.
27. Skowronski DM, Hottes TS, McElhaney JE, Janjua NZ, Sabaiduc S, et al. (2011) Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age. J Infect Dis 203: 158-167.
28. Zimmer SM, Crevar CJ, Carter DM, Stark JH, Giles BM, et al. (2010) Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS One 5: e11601.
29. Chen H, Wang Y, Liu W, Zhang J, Dong B, et al. (2009) Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis 15: 1849-1850.
30. Ikonen N, Strengell M, Kinnunen L, Osterlund P, Pirhonen J, et al. (2010) High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill 15.
31. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
32. Epstein SL, (2006) Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 193: 49-53.
33. Skowronski DM, Hottes TS, Janjua NZ, Purych D, Sabaiduc S, et al. (2010) Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ 182: 1851-1856.
34. Waalen K, Kilander A, Dudman SG, Krogh GH, Aune T, et al. (2010) High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill 15.
35. Hardelid P, Fleming D, McMenamin J, Andrews N, Robertson C, et al. (2011) Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill 16.
36. Kunzel W, Glathe H, Engelmann H, Van HC, (1996) Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 14: 1108-1110.
37. Silvennoinen H, Peltola V, Lehtinen P, Vainionpaa R, Heikkinen T, (2009) Clinical presentation of influenza in unselected children treated as outpatients. Pediatr Infect Dis J 28: 372-375.
38. Carrat F, Pelat C, Levy-Bruhl D, Bonmarin I, Lapidus N, (2010) Planning for the next influenza H1N1 season: a modelling study. BMC Infect Dis 10: 301.
39. Rimmelzwaan GF, McElhaney JE, (2008) Correlates of protection: novel generations of influenza vaccines. Vaccine 26 (Suppl 4): D41-D44.
40. Xing Z, Cardona CJ, (2009) Preexisting immunity to pandemic (H1N1) 2009. Emerg Infect Dis 15: 1847-1849.
41. Hobson D, Curry RL, Beare AS, Ward-Gardner A, (1972) The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 70: 767-777.
42. Health Protection Agency. (2011) 2010/11 National Influenza Annual Report. Available online: http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/SeasonalInfluenza/EpidemiologicalData/07influsInfluenzaannualreports.
43. Haut Conseil de la Sante Publique, 2010 [Advice regarding the updating of the influenza 2010-2011 vaccine strategy]. Avis relatif à l'actualisation de la stratégie vaccinale contre la grippe 2010-2011. http://www.hcsp.fr/docspdf/avisrapports/hcspa20101229_actuavacgrippe.pdf. Accessed 2011 June 08.